Regardless of amplification, ALK overexpression is widely observed in nearly 100% of basal cell carcinoma [25] and in more than 50% of neuroblastomas, with only 10% of primary neuroblastomas displaying also ALK gene amplification. The gene discussed is ALK; the disease is neuroblastoma.